Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents
Prescrire international 18(104): 251
2009
ISSN/ISBN: 1167-7422 PMID: 20025091 Document Number: 632358
Document emailed within 1 workday
Related Documents
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117
Lisoprawski, A. 1983: Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(25): 1925-1927
Ryzhakov, B.A.; Nuller, I.U. 1992: The use of the bromocriptine test in schizophrenia patients resistant to neuroleptic therapy Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(3): 79-80
Sayed, Y.; Garrison, J.M. 1983: The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review Psychopharmacology Bulletin 19(2): 283-288
Wiesel, F.A. 1994: Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance British Journal of Psychiatry. Suppl 23: 65-70
Mintz, M.; Tomer, R.; Myslobodsky, M.S. 1982: Neuroleptic-induced lateral asymmetry of visual evoked potentials in schizophrenia Biological Psychiatry 17(7): 815-828
Elie, R.; Gagnon, M.A.; Gauthier, R.; Jéquier, J.C. 1975: Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia L'Union Medicale du Canada 104(6): 909-914
Johnson, D.A. 1984: Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia Journal of Clinical Psychiatry 45(5 Part 2): 13-21
Reddi, K. 1985: Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to "tardive" dyskinesia independent of extent of neuroleptic medication Irish Medical Journal 78(9): 270
Lindholm, H.; Ljungberg, L. 1973: Comparison of conventional neuroleptic therapy with depot neuroleptics. An attempt at economic evaluation Acta Psychiatrica Scandinavica. Supplementum 246: 52-56
Diomšina, B.; Rasmussen, P.Darling.; Danilevičiütė, V. 2015: Clinical Experience of Long-Term Treatment with Aripiprazole (Abilify) in Children and Adolescents at the Child and Adolescent Psychiatric Clinic 1 in Roskilde, Denmark Acta poloniae pharmaceutica 72(3): 597-606
Tempest, M.; Sapin, C.; Beillat, M.; Robinson, P.; Treur, M. 2015: Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK Journal of Mental Health Policy and Economics 18(4): 185-200
Cañive, J.M.; Lewine, J.D.; Edgar, J.C.; Davis, J.T.; Miller, G.A.; Torres, F.; Tuason, V.B. 1998: Spontaneous brain magnetic activity in schizophrenia patients treated with aripiprazole Psychopharmacology Bulletin 34(1): 101-105
Kostowski, W.; Płaznik, A. 1984: Neuroleptic drugs Wiadomosci Lekarskie 37(3): 233-236
Till, E.; Vucković, S.; Lisulov, R.; Nedić, A. 1989: The neuroleptic malignant syndrome Medicinski Pregled 42(11-12): 419-423
Martínez, E.; Domingo, P.; Lloret, J. 1994: Malignant neuroleptic syndrome Medicina Clinica 102(5): 181-188
Johannessen, J.O.; Bergrem, H. 1989: Neuroleptic malignant syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(6): 696-697
Casas Fernández-Tejerina, J.; Pérez de Diego, I.; Estrada Castrillo, P.; Merino Angulo, J. 1987: Neuroleptic malignant syndrome Revista Clinica Espanola 180(7): 407-408
Gunne, L.M. 1974: Neuroleptic medication questioned Lakartidningen 71(12): 1161-1162